ICMR slams Covaxin study for poor methodology

21 May,2024 07:35 AM IST |  New Delhi  |  Agencies

The ICMR is not associated with the study and has not provided any financial or technical support for the research, Dr Bahl said

ICMR is not associated with study


The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" ICMR.

Dr Bahl said the study had no control arm of unvaccinated individuals for comparing the rates of events between the vaccinated and unvaccinated groups. Hence, the reported events in the study cannot be linked or attributed to COVID-19 vaccination.

The ICMR is not associated with the study and has not provided any financial or technical support for the research, Dr Bahl said.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!
news india national news India news Coronavirus Covid 19
Related Stories